Skip to main content
ENDO 2026 Main banner

INC01 - Redefining Desmopressin Therapy for Central Diabetes Insipidus (CDI), also known as Arginine Vasopressin Deficiency (AVP-D)

Sunday, June 14, 2026
10:30 AM - 11:00 AM CT
Location: ENDOExpo

    Speaker(s)

  • LB

    Lewis Blevins

    Director of the California Center for Pituitary Disorders

This presentation reviews the pathophysiology and clinical features of CDI/AVP-D, with a focus on building a comprehensive understanding of current treatment options, diagnostic testing, and established standards of care, while also highlighting the risks and clinical implications of hyponatremia.